Teva Pharmaceutical Industries Limited (TEVJF) has a profit margin of 2.94%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for TEVJF is 2.94% as of September 2026. That compares with 4.24% in the prior-year period — down 30.8% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Teva Pharmaceutical Industries Limited's historical trend and sector peers before judging valuation or financial health.
Over the past year, TEVJF's profit margin moved from 4.24% to 2.94% — a 30.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Teva Pharmaceutical Industries Limited's valuation or profitability profile.
Against Healthcare companies, TEVJF currently prints 2.94% for profit margin, while the sector average sits near 17.63%. That is roughly 83.3% below the sector mean. Large gaps often invite a closer look at Teva Pharmaceutical Industries Limited's growth, margins, and balance sheet.
Profit Margin shows how effectively Teva Pharmaceutical Industries Limited converts resources into returns. At 2.94%, TEVJF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.24% in the prior-year period — down 30.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TEVJF's profit margin (2.94%), review year-over-year change from 4.24%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.